We also demonstrate that HMGCLL1 polymorphism is functionally relevant for CML cell growth and viability, and that HMGCLL1 blockade is cytotoxic to CML cells. This evidence concerns the gene HMGCLL1 and chronic myelogenous leukemia, BCR-ABL1 positive.